Codes and Frequencies
An 'X' indicates the category is available for that sample
Code | Label |
burun
87
|
egypt
88
|
ghana
88
|
kenya
89
|
mali
87
|
seneg
86
|
sril
87
|
sud
89
|
togo
88
|
tunis
88
|
ugand
88
|
zimbw
88
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
00 | No problem | X | X | X | X | X | X | X | X | X | X | X | X |
10 | Religious prohibition | · | X | · | X | · | · | · | X | · | X | · | · |
20 | Not effective | X | X | X | X | X | X | X | X | X | X | X | X |
30 | Others disapprove | · | X | · | X | · | · | · | X | · | · | · | · |
31 | Husband disapproves | X | X | X | X | X | X | X | X | X | · | X | X |
40 | Side effects/health concerns | X | · | X | X | X | X | X | X | X | X | X | X |
41 | Side effects for woman | · | X | · | · | · | · | · | · | · | X | · | · |
42 | Side effects for child | · | X | · | · | · | · | · | · | · | · | · | · |
50 | Access or availability | X | X | X | X | X | X | X | X | X | X | X | X |
60 | Costs too much | X | X | X | X | X | X | X | · | X | · | X | X |
70 | Inconvenient to use | · | X | X | X | · | · | X | X | · | X | X | X |
71 | Difficult to use | · | · | · | · | · | · | · | · | X | X | · | · |
72 | Unpleasant to use | · | · | · | · | · | · | · | · | · | X | · | · |
73 | Forget to use | · | · | · | · | · | · | · | · | · | X | · | · |
74 | Bad experience | · | · | · | · | · | · | · | · | · | · | · | · |
75 | Embarrassing to use | X | X | · | · | · | · | · | X | · | X | X | X |
90 | Other | X | X | X | X | X | X | X | X | X | X | X | X |
96 | Inconsistent | · | · | · | · | · | · | · | · | · | · | · | · |
97 | Don't know | X | X | X | X | X | X | X | X | X | X | X | X |
98 | Missing | X | X | X | X | X | · | X | X | X | · | X | X |
99 | NIU (not in universe) | X | X | X | X | X | X | X | X | X | X | X | X |
Can't find the category you are looking for? Try the Detailed codes
Description
FPPROBINJS2 (V308_03) reports the woman's opinion about the main problem, if any, with using injectables (such as Depo-Provera) as a family planning method. Interviewers collected the information through an open-ended question and then recorded the woman's response using country-specific codes.
IPUMS-DHS interested in using FPPROBINJS2 may also be interested in FPPROBINJS, which coded the woman's response using standard response categories.
Comparability
Along with changes in the universe and minor question wording differences, FPPROBINJS2 (V308_03) varies across samples in the number and type of responses.
To maximize comparability across samples, IPUMS-DHS uses composite coding and a 2-digit coding system. The first digit broadly distinguishes between different problems (e.g., side effects/health concerns), and the second digit provides additional detail within these initial groupings (e.g., side effects for woman versus side effects for child).
The label for and description of contraceptive methods varies slightly across samples. For exact question wording for samples of interest, consult the Survey Text tab.
Comparability - Standard DHS
FPPROBINJS2 (V308_03) was included in the standard DHS questionnaire for Phase 1 only.
Universe
- Burundi 1987: Women age 15-49 who have heard of injectables.
- Egypt 1988: Ever-married women age 15-49 who have heard of injectables.
- Ghana 1988: Women age 15-49 who have heard of injectables.
- Kenya 1989: Women age 15-49 who have heard of injectables.
- Mali 1987: Women age 15-49 who have heard of injectables.
- Senegal 1986: Women age 15-49 who have heard of injectables.
- Sri Lanka 1987: Ever-married women age 15-49 who have heard of injectables.
- Sudan 1989: Ever-married women age 15-49 who have heard of injectables.
- Togo 1988: Women age 15-49 who have heard of injectables.
- Tunisia 1988: Ever-married women age 15-49 who have heard of injectables.
- Uganda 1988: Women age 15-49 who have heard of injectables.
- Zimbabwe 1988: Women age 15-49 who have heard of injectables.

Loading...